LMNA and Hutchinson-Gilford progeria syndrome: Injections of the proteasome inhibitor MG132 also resulted in an autophagy-mediated enhanced progerin turnover in HGPS patient fibroblasts, HGPS patient iPSC-derived mesenchymal stem cells, vascular smooth muscle cells, and LmnaG609G/G609G progeric mouse model [157].